Over 2 years (FY 2023 to FY 2025), Gain on sale of Telavant net assets shows a downward trend with a -100.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
A gain indicates successful monetization of assets, while a loss may suggest divestment under unfavorable conditions.
This metric captures the net financial impact from the divestiture of specific business units or significant assets. It...
Non-recurring item; peers are evaluated on the strategic rationale behind such divestitures.
other_gain_loss_on_sale_of_assets| Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $5.35B | $0.00 | $110.39M | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| QoQ Change | — | — | — | — | — | -100.0% | — | -100.0% | — | — | — | — | — | — |
| YoY Change | — | — | — | — | — | — | — | — | -100.0% | — | -100.0% | — | — | — |
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 |
|---|---|---|---|---|
| Reportable Segment | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $0.00 | $0.00 | $0.00 | $0.00 |